Loading clinical trials...
Loading clinical trials...
A Phase I Study of SAHA and Temozolomide in Children With Relapsed or Refractory Primary Brain or Spinal Cord Tumors
Conditions
Interventions
vorinostat
temozolomide
+2 more
Locations
9
United States
Childrens Memorial Hospital
Chicago, Illinois, United States
C S Mott Children's Hospital
Ann Arbor, Michigan, United States
University of Minnesota Medical Center-Fairview
Minneapolis, Minnesota, United States
Oregon Health and Science University
Portland, Oregon, United States
St. Jude Children's Research Hospital
Memphis, Tennessee, United States
Baylor College of Medicine
Houston, Texas, United States
Start Date
February 1, 2010
Primary Completion Date
October 1, 2012
Last Updated
May 3, 2013
NCT02684071
NCT00326664
NCT00100880
NCT00281944
Lead Sponsor
National Cancer Institute (NCI)
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions